Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.55USD
4:00pm EDT
Price Change (% chg)

$-0.01 (-2.57%)
Prev Close
$0.56
Open
$0.54
Day's High
$0.55
Day's Low
$0.54
Volume
13,390
Avg. Vol
--
52-wk High
--
52-wk Low
--

ACST.OQ

Chart for ACST.OQ

About

Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)
No analyst recommendations are available for ACST.OQ.

Overall

No Ratios Available.

Financials

  ACST.OQ Industry Sector
P/E (TTM): -- 32.90 33.54
EPS (TTM): -- -- --
ROI: -- 18.34 17.61
ROE: -- 19.01 18.42
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks